
Search
Selected Filter
Filter Results
Displaying 1–10 of 179 diseases results
-
Feb 10, 2025
Pioneering Delivery Strategies for Blinding Diseases Therapy and Inspiring Women in Science
International Day of Women and Girls in Science is celebrated globally to recognize the critical role women play in science, technology, engineering, and mathematics. To honor this vital day, the Foundation is thrilled to spotlight Dr. Renee Ryals, PhD, a remarkable scientist at the Casey Eye Institute, Oregon Health & Science University.
-
Jan 27, 2025
Eva Lou Schroeder Watson's Enduring Legacy
Eva Watson’s life was marked by her dedication to advancing medical research for blinding diseases, and her generous bequest to the Foundation Fighting Blindness ensures her advocacy will endure. Her story highlights the profound impact of her contributions to driving treatments and cures for blinding diseases.
-
Jan 24, 2025
Eye on the Cure Podcast | Episode 80: Aniz Girach, MD
Aniz Girach talks about the company’s emerging protein-splicing therapy for Stargardt disease which has received clearance from the FDA to move into a clinical trial.
-
Jan 10, 2025
Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy
The Foundation is a founding investor in Atsena.
-
Jan 10, 2025
Eye on the Cure Podcast | Episode 79: Damon Lembi
Damon Lembi talks about his journey as a college baseball star, father, and CEO of Learnit.
-
Dec 20, 2024
The company is also planning to conduct the clinical trial at sites in the EU.
-
Dec 20, 2024
Eye on the Cure Podcast | Episode 78: Dr. Sheldon Rowan
Dr. Rowan talks about the impact of the glycemic index, microbiome, and diet on the development of age-related macular degeneration and optimization of overall retinal health.
-
Dec 16, 2024
The company has also launched a natural history study of patients to inform the planned clinical trial.
-
Dec 16, 2024
Staying True to Music, Family, and Advocacy
Music duo Andrew & Polly have earned a GRAMMY nomination for their children’s album “Ahhhhh!” while also championing disability awareness and inclusivity. Andrew’s experience with Stargardt disease fuels their advocacy, inspiring others through their music, podcast, and dedication to research and community support.
-
Dec 13, 2024
Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy
Known as ultevursen, the USH2A RNA therapy was licensed from ProQR.